Kurt A. Gustafson
2013 - Spectrum Pharmaceuticals
In 2013, Kurt A. Gustafson earned a total compensation of $2.4M as Executive Vice President and Chief Financial Officer at Spectrum Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $1,109,255 |
| Salary | $262,500 |
| Stock Awards | $821,000 |
| Other | $45,924 |
| Total | $2,438,679 |
Gustafson received $1.1M in option awards, accounting for 45% of the total pay in 2013.
Gustafson also received $200K in bonus, $262.5K in salary, $821K in stock awards and $45.9K in other compensation.
Rankings
In 2013, Kurt A. Gustafson's compensation ranked 3,211th out of 12,286 executives tracked by ExecPay. In other words, Gustafson earned more than 73.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,211 out of 12,286 | 74th |
Division Manufacturing | 1,088 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 282 out of 1,462 | 81st |
Industry group Drugs | 193 out of 1,156 | 83rd |
Industry Pharmaceutical Preparations | 160 out of 890 | 82nd |
Source: SEC filing on April 29, 2016.
Gustafson's colleagues
We found five more compensation records of executives who worked with Kurt A. Gustafson at Spectrum Pharmaceuticals in 2013.
2013
Rajesh Shrotriya
Spectrum Pharmaceuticals
Chief Executive Officer
2013
Joseph Keller
Spectrum Pharmaceuticals
Chief Operating Officer
2013
Lee Allen
Spectrum Pharmaceuticals
Chief Medical Officer
2013
Joseph Turgeon
Spectrum Pharmaceuticals
Chief Operating Officer
2013
Brett Scott
Spectrum Pharmaceuticals
Senior Vice President, Finance
News
OmniAb CEO Matthew Foehr's 2023 pay falls 60% to $2.6M
April 26, 2024
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019